Market size, growth to 2033 and clinical trials, side by side.
China is the bigger Fertility Service market: $1.7 Bn against $382 Mn in 2023, about 4.4 times as large.
India grows faster: 9.1% a year, against 7.6%. The gap still grows from $1.3 Bn to $2.6 Bn by 2033.
Clinical research: 55 active trials in China, 2 in India.
| Measure | ||
|---|---|---|
| Market size, 2023 | $1.7 Bn | $382 Mn |
| Market size, 2033 projected | $3.5 Bn | $912 Mn |
| Growth a year (CAGR) | 7.6% | 9.1% |
| Money added, 2023–2033 | $1.8 Bn | $531 Mn |
| Share of the world market | 8% | 1.8% |
| Size rank of 24 countries | #2 | #12 |
| Market per person, 2023 | $1.20 | $0.26 |
| Active clinical trials | 55 | 2 |
| Full report | China report | India report |
China India · values between 2023 and 2033 are projected from the 2023 size and the CAGR.
China is the bigger Fertility Service market: $1.7 Bn against $382 Mn in 2023, about 4.4 times as large.
India grows faster: 9.1% a year, against 7.6%. The gap still grows from $1.3 Bn to $2.6 Bn by 2033.
Sources: market size and growth: Acuitas Health Analytics research (2023 base year, forecasts to 2033). Trials: ClinicalTrials.gov (fetched 10 Nov 2026); found by search words, so counts are a guide. Population: World Bank.